COMMUNIQUÉS West-GlobeNewswire

RadioMedix and AREVA Med announce initiation of Phase 1 clinical trial of AlphaMedix(TM), a Targeted Alpha Therapy for patients with neuroendocrine tumors
10/01/2018
Houston, TX (USA) and Courbevoie (France), Jan. 10, 2018 (GLOBE NEWSWIRE) -- RadioMedix Inc. and AREVA Med today announced the initiation in the United States of Phase 1 trial for AlphaMedix TM in patients with [...]
Medibio Announces ISO 13485 Certification
10/01/2018
SYDNEY, Australia and MINNEAPOLIS, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX:MEB) (OTCQB:MDBIF) has received a Certificate of Compliance certifying that the Company’s Quality [...]
Basilea announces completion of the license agreement extension with Pfizer for antifungal Cresemba® for China and Asia Pacific
10/01/2018
Basel, Switzerland, January 10, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today the completion of its extension of its license agreement with Pfizer Inc. (NYSE: PFE) for Basilea's antifungal Cresemba ® ( [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
10/01/2018
REGULATED INFORMATION GHENT, Belgium, 10 January 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Business Celebrates 160 Years in Louisville
10/01/2018
LOUISVILLE, Ky., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Louisville is known for manufacturing many products, but even before the Louisville Slugger ® bat was created, and bourbon was first bottled, the American Printing [...]
Anthera Pharmaceuticals Announces Second Closing of $15 Million Private Placement Offering
09/01/2018
HAYWARD, Calif., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ) today announced that it has completed the second closing of the private placement of its equity securities (“PIPE”) with [...]
Emerald Announces Closing of $15 Million Prospectus Sale
09/01/2018
VICTORIA, British Columbia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) ("Emerald" or the “Company”) closed today its prospectus sale (the “Offering”) to a single [...]
Humana Extends Partnership with Tivity Health to Provide SilverSneakers® Through 2022
09/01/2018
NASHVILLE, Tenn. and LOUISVILLE, Ky., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Tivity Health (NASDAQ: TVTY ) and Humana Inc. (NYSE: HUM ) today announced that they have extended their existing partnership through December 31, [...]
Major Shareholder Announcement
09/01/2018
Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; January 9, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 29 of the Danish Securities Trading Act [...]
21st Century Oncology Receives Court Approval of Plan of Reorganization
09/01/2018
FORT MYERS, Fla., Jan. 09, 2018 (GLOBE NEWSWIRE) -- 21st Century Oncology Holdings, Inc., the largest global provider of integrated cancer care services, announced today that the United States Bankruptcy Court for the [...]
5 Ways to Use Petroleum Jelly for Skin Care; American Academy of Dermatology
09/01/2018
SCHAUMBURG, Ill., Jan. 09, 2018 (GLOBE NEWSWIRE) -- The skin is the body’s largest organ, so it’s important to take good care of it. However, doing so doesn’t necessarily mean breaking the bank, say dermatologists from [...]
Predictive Technology Group Finalizes Letter of Intent to Acquire FlagshipHealth Group
09/01/2018
SALT LAKE CITY, Utah, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK:PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through [...]
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2017
09/01/2018
Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2017 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]
Essilor: Nombre total de droits de vote et d'actions composant le capital social au 31 décembre 2017
09/01/2018
Nombre total de droits de vote et d'actions composant le capital social au 31 décembre 2017 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, [...]
EHNAC’s Executive Director Provides Comment on ONC Draft of Trusted Exchange Framework
09/01/2018
FARMINGTON, Conn., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Last week, the Department of Health and Human Services’ (HHS) Office of the National Coordinator for Health Information Technology (ONC), issued its draft Trusted [...]
Misonix to Ring Nasdaq Closing Bell on January 10
09/01/2018
FARMINGDALE, N.Y., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON ) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Michael Tempel, MD, is Elected to the American Health Council’s Board of Physicians
09/01/2018
NEW YORK, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Michael Tempel, MD, has been elected to the American Health Council’s Board of Physicians. Dr. Tempel utilizes his expertise as a General Surgeon for the Lima Memorial Health [...]
Abattis Announces LOI for Partnership with Alliance of Beverage Licensees
09/01/2018
VANCOUVER, British Columbia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce it has signed a letter of intent (“LOI”) with the [...]
On changes in the Board of JSC “Grindeks”
09/01/2018
JSC “Grindeks” announced the company’s Supervisory Council has re-elected Juris Bundulis as its Chairman of the Board and elected Ph.D. Juris Hmelnickis in the Board of JSC “Grindeks”. Juris Hmelnickis is Quality [...]

Pages